Japanese researchers have reported the effect of a particular type of monoclonal antibody on epilepsy in mice, with promising results. [ + ]

Researchers have uncovered a novel mechanism behind excessive platelet production present in people with diabetes, placing them at increased risk of cardiovascular complications such as heart attack and stroke. [ + ]

The Australian Academy of Science has inducted 21 of Australia's best scientists for their outstanding contributions to science. [ + ]

Actinogen Medical has recruited and treated the first patient as part of its Phase II clinical trial of Xanamem, the biotech company's cortisol-blocking drug. [ + ]

Australian researchers have achieved a major breakthrough in the fight against advanced melanoma, giving hope to over 1800 Australians expected to die from the deadly disease this year. [ + ]

Nominations for GSK's Award for Research Excellence are now open until 10 July 2017. [ + ]

Leaders from the Australian Nuclear Science and Technology Organisation (ANSTO), experts from Italy and clinicians from NSW recently met to explore how the full range of particle therapy treatments may be made available to Australians. [ + ]

Science and technology company Merck has developed a new genome editing tool that is said to make CRISPR more efficient, flexible and specific. [ + ]

Trajan Scientific and Medical (Trajan) has expanded its organisational and global manufacturing footprint with the opening of a Penang Malaysia facility. [ + ]

Australian-listed, clinical-stage oncology company PharmAust has secured a new patent in Australia covering the use of its lead drug for non-cancer applications, including neurodegenerative diseases, diabetes and age-related disorders. [ + ]

The Australian National University (ANU) is inviting citizen scientists with an interest in astronomy to join a search for exploding stars called supernovae. [ + ]

Scientists have found that cancer immunotherapy, intended to boost the body's immune system in order to fight tumours, may actually be having the opposite effect in some cancers. [ + ]

Scientists at Sydney's Garvan Institute of Medical Research have discovered that 'tumour-trained' immune cells — which have the potential to kill cancer cells — move from one tumour to another. [ + ]

The Annual Conference of China Scientific Instruments (ACCSI) has recognised the Micromeritics GeoPyc 1365 as one of the leading new instruments introduced in China in 2017. [ + ]

Australian researchers have grown brain cells on a semiconductor wafer patterned with nanowires which act as a scaffold to guide the growth of brain cells. [ + ]